Charles River Laboratories | CRL - Selling And Administration Expenses

Stock Price
168.92
Daily Change
4.68 2.85%
Monthly
-25.51%
Yearly
3.62%
Q1 Forecast
163.68

Charles River Laboratories reported $196.14M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Agilent USD 428M 37M Sep/2025
Align Technology USD 441.68M 23.88M Dec/2025
Bio-Rad Laboratories USD 206.8M 900K Sep/2025
Bruker USD 247.2M 4.7M Dec/2025
Cardinal Health USD 1.5B 43M Dec/2025
Charles River Laboratories USD 196.14M 18.55M Dec/2025
Cigna USD 3.19B 242M Sep/2025
Concord Medical Services Hldg CNY 176.6M 39.16M Jun/2023
Danaher USD 2.03B 35M Dec/2025
Dentsply International USD 355M 21M Sep/2025
Elevance Health USD 10.91B 309M Dec/2025
Galapagos EUR 34.55M 3.88M Sep/2025
Hologic USD 2.5B 2.24B Dec/2025
Humana USD 3.36B 614M Mar/2025
Illumina USD 283M 27M Dec/2025
Incyte USD 390.41M 61.33M Dec/2025
Intrexon USD 10.31M 41K Jun/2024
IQVIA Holdings USD 468M 46M Dec/2025
Laboratory Of America USD 538.6M 13.8M Dec/2025
McKesson USD 2.03B 44M Dec/2025
Merck EUR 1.46B 16M Sep/2025
Mettler Toledo International USD 259.83M 11.43M Dec/2025
Novartis USD 3.31B 134M Sep/2025
Pfizer USD 4.08B 894M Dec/2025
Quest Diagnostics USD 504M 3M Dec/2025
Revvity USD 251.73M 9.82M Dec/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
United Therapeutics USD 152M 60.5M Sep/2025
UnitedHealth USD 15.22B 1.44B Sep/2025
Veradigm USD 32.52M 27.13M Sep/2022
Waters USD 240.01M 25.78M Dec/2025
West Pharmaceutical Services USD 106.5M 3.8M Dec/2025